Healthcare and Life Science
SPT Labtech continues to support UKHSA genomics surveillance project to bolster global health security
Cambridge – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, continues its partnership with the UK Health Security Agency (UKHSA) to advance global genomics surveillance. SPT Lab...
Launching evolue - hello World
Hello World We are excited to announce the official launch of evolue, a dynamic agile consultancy, that is committed to empowering organisations and individuals in navigating the ever-changing landscape of today's world. About Us: ...
MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space
Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients. Investment led by Mercia Ventures, with Calculus Capital and Angel investors also pa...
Optibrium enables collaborative design in its StarDrop platform
The new Idea Tracker capability further improves the efficiency of drug discovery by supporting project management, idea sharing and molecule design tracking The software promotes collaboration within and across teams for more cohesive workflows ...
Cambridge Science Centre welcomes new trustee to its Board
Harriet Fear, MBE, has recently joined the Cambridge Science Centre Board, bringing with her extensive expertise that complements the current Board's strengths, led by Dr David Cleevely. ...
ELRIG UK announces Steve Bates and Dr Anderson Ryan as Keynote Speakers at Research and Innovation 2024
ELRIG Research and Innovation 2024 takes place from 20–21 March in Manchester, UK Key topics include oncology, antimicrobial resistance, mass spectrometry, proteomics and animal-free drug discovery Launch of TechBio Breakthrough Zone offers young companies an opportunity to showcas...
The Ozempic Dilemma: What makes a dual-brand approach viable?
This article was originally published in Life Science Leader.
Inbiomotion and Source BioScience sign an exclusive agreement for MAF Test® in United Kingdom and Ireland
This pioneering test aids oncologists in predicting recurrence and survival rates in breast cancer patients and potential treatment eligibility to bisphosphonates Results showing the clinical utility of the test have been published in Lancet Oncology and the Journal of National Cance...
Closed Loop Medicine demonstrates application of novel drug plus software product for personalized treatment of hypertension
Study published in JAHA validates use of proprietary technology to identify personalized dose regimen, leading to improved blood pressure control and exceptionally high adherence in hypertension patients Findings will guide the Company’s strategy to expand portfolio of differentiated...
BioPartner UK appoints Strategic Communications Specialist Dr Priya Kalia to Advisory Board
BioPartner UK, the independent, accredited trade organisation, announces the appointment of Dr Priya Kalia, Managing Director of SciTribe Ltd, to its Advisory Board. BioPartner UK’s Advisory Board includes senior investors, executive and non-executive directors, and business development...